Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844310037 ISBN 13: 9783844310030
Librería: preigu, Osnabrück, Alemania
EUR 43,30
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. The Promises and Perils of Real Options Valuation Technique. | An in-depth analysis of Real Options Valuation technique, in Pharmaceutical R&D industry. By means of a case study research method | Mayank Gupta | Taschenbuch | 76 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783844310030 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Feb 2011, 2011
ISBN 10: 3844310037 ISBN 13: 9783844310030
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 49,00
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry. 76 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844310037 ISBN 13: 9783844310030
Librería: moluna, Greven, Alemania
EUR 41,05
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: GUPTA MAYANKI have completed my MSc. program in Strategic Project Management (European). My research interests are in the areas of financial economics specifically on Efficient Market Hypothesis, and capital budgeting for making in.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Feb 2011, 2011
ISBN 10: 3844310037 ISBN 13: 9783844310030
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 49,00
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844310037 ISBN 13: 9783844310030
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 49,00
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.